RIBOCYGNUS
"RIBOCYGNUS" is a word mark owned by Suzhou Ribo Life Science Co., Ltd., filed at the USPTO on June 16, 2026. It is under examination and covers classes 5 and 42.
- Status
- Under examination
- Since October 27, 2026
- Filed
- June 16, 2026
- Registered
- Not yet
- Priority date
- June 5, 2026
- Claimed from China
- Application no.
- 99888114
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns RIBOCYGNUS
The owner and representative on file with the office.
Owner
Suzhou Ribo Life Science Co., Ltd.
Kunshan City, Jiangsu, China
Representative
Zhi Dong
HSML, P. C.
What the mark covers
The products and services RIBOCYGNUS is filed for, grouped by Nice class.
Medicines for humans for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; crude drugs being pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders , nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders , nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; Biological preparations for use in cell cultures for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral disease; diagnostic preparations for medical purposes; Phosphates for pharmaceutical purposes; sodium salts for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the peripheral nervous system; antidepressants; antiepileptic pharmaceutical preparations; pain relief medication; balsamic preparations for medical purposes; pharmaceutical preparations for the treatment of infectious diseases; pharmaceuticals for the treatment of viral diseases; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; Anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; pharmaceuticals for ophthalmological use; nucleic acid sequences for medical and veterinary purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; Medical dressings; Composite materials for dental and dental technical purposes; cardiovascular agents for medical purposes; anti-diabetic preparations; Pharmaceutical agents affecting peripheral nervous system; analgesics; Analgesic preparation; Antivirals; pharmaceutical preparations for the treatment of viral diseases; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; Anti-cancer preparations; biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; antihypertensives; hypolipidemic agents; Cholesterol reducers; ophthalmological preparations; diapers for pets
technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; Development services of drugs; pharmaceutical product evaluation; Research and development services of new pharmaceutical products; Research and development in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; Development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design
What has happened so far
Steps recorded by the USPTO, newest first.
- Assigned to examiner
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About RIBOCYGNUS
Who owns the trademark "RIBOCYGNUS"?
The USPTO trademark "RIBOCYGNUS" (application 99888114) is owned by Suzhou Ribo Life Science Co., Ltd.
What is the status of "RIBOCYGNUS"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull RIBOCYGNUS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019ed925-661e-703b-a5dd-7de7c9a0f612
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019ed925-661e-703b-a5dd-7de7c9a0f612",
"object": "trademark",
"mark_text": "RIBOCYGNUS",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "99888114",
"filing_date": "2026-06-16",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Suzhou Ribo Life Science Co., Ltd.",
"entity_id": null
}
]
}